a new oral drug for leukemia called Tasigna

December 2007

You'll hear about a new oral drug for leukemia called Tasigna.

Tasigna (nilotinib) is an oral kinase inhibitor...similar to Gleevec (imatinib) or Sprycel (dasatinib).

Tasigna and Sprycel are for cases that are resistant to Gleevec.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote